Patientimpact LLC Evanston, IL - 60201

Patientimpact LLC is categorized under Market Research and Analysis in Evanston, IL and active since 2009.

Patientimpact LLC was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Market Research and Analysis business, which does work in the B2B market, and is classified as a Market Research and Analysis, under code number 541910 by the NAICS.

If you are seeking more information, feel free to contact Kenneth R Draughon at the company’s single location by writing to 1560 Sherman Avenue # 305, Evanston, Illinois IL 60201 or by phoning (847) 556-2398. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Patientimpact LLC
Contact Person: Kenneth R Draughon
Address: 1560 Sherman Avenue # 305, Evanston, Illinois 60201
Phone Number: (847) 556-2398
Website Address: pressganey.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Market Research and Analysis
SIC Code: 8732
NAICS Code: 541910
Share This Business:

Patientimpact LLC was started in 2009 to provide professional Market Research and Analysis under the SIC code 8732 and NAICS code 541910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Kenneth R Draughon for inquiries that concern Patientimpact LLC by calling the company number (847) 556-2398, as your correspondence is most welcome. Additionally, the physical location of the single location of Patientimpact LLC can be found at the coordinates 42.045737,-87.682058 as well as the street address 1560 Sherman Avenue # 305 in Evanston, Illinois 60201.

For its online presence, you may visit Patientimpact LLC’s website at pressganey.com and engage with its social media outlets through on Twitter and on Facebook.